End-to-End Biologics CDMO|OPM Biosciences – Cell Culture Media and End-to-End CDMO

End-to-End Biologics CDMO Services

A comprehensive platform with antibody discovery,

cell line development, upstream & downstream process development,

and pilot and phases I&II manufacturing

You need to move fast but with reasonable resources?

Our highly efficient End-to-End biologics CDMO service platform has been designed to support therapeutic antibodies and recombinant proteins from DNA to IND application and till BLA submission.

Our services range from antibody humanization engineering to stable cell line development, cell culture and purification process development, formulation development, IND application at NMPA, FDA and EMA, and pilot scale production (200L/500L) for clinical trials.